BeatTheStreet

$COIN Feels better than feared, but $MSTR CFO leaving is pressuring crypto

$ALNY Whats it worth, but Oppenheimer out saying stock priceing in worst case scenario and 340B R7R skewed upside now...would think buyers step in tomorrow

$AMZN $SNDK $INTC $PINS $TWLO $RBLX ouccchhh... wheres the beats?

$INTC INTEL SEES 4Q REVENUE $15B TO $16B, EST. $17.05B...ouch

$CBRS Hearing Mizuho out defending the name, product life fears overdone..buying the pullback

$WHR Just cant get house in order so downward revisions will continue. Debt reduction to $4.5bln by year end seems overly optimistic...

$ALNY Weekly US sales hit 80mln mark +22% vs previous week

$RAPP Several insider buys filed again

$BHVN Vyglxia back in our model at Jefferies now pt goes from $25 to $29

$BHVN DB adds Vyglyxia back to model and hikes pt to $26 from $20

$META Hearing Mizuho hikes pt to $950 from $750

$TTMI I get that DC/Networking missed the mark, but company beat all other segements and raised 2027 above consensus, feels a little overreaction trading lower 27%

$RAPP Nice boost of confidence by CFO sec.gov/Archives/edgar/data/…

$SPCX Raymond James assumes $800 pt

$SPCX Now JPM taks pt to $500

$SPCX Hearing Citi adds to upside catalyst watch

$ORCL Oracle been saved by $NVDA per Cowen...just another usual day

$EVMN Evommune (EVMN $5.27) assumed overweight; target is $26, 393% upside .... MS This name has been cratering since mid august in stright line with mcap below cash now @ $5.27

$ABVX Abivax (ABVX $87.49) assumed overweight; target is $180, 106% upside..MS

$VKTX Not a bad track from UBS new analyst on covered names tipranks.com/experts/analyst…